Botanical species · safety record
Dracocephalum moldavica
The EFSA Compendium of Botanicals holds 17 constituent measurements for Dracocephalum moldavica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Dracocephalum moldavica L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- 1,8-cineole2
- Apiole2
- Camphor2
- Fenchone2
- Myrcene2
- Alpha-thujone1
- Beta-thujone1
- Carvone1
- Methyleugenol1
- Methylisoeugenol1
Plant parts
- Unspecified16
- Aerial part of plants1
Preparations
- Essential oil16
- Solvent extraction1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| 1,8-cineole | Unspecified | Essential oil | 2.21 Percent | GC-MS | Resolve DOI |
| 1,8-cineole | Unspecified | Essential oil | ≤ 1.5 Percent | GC-MS | Resolve DOI |
| Alpha-thujone | Unspecified | Essential oil | ≤ 1.9 Percent | GC-MS | Resolve DOI |
| Apiole | Unspecified | Essential oil | ≥ 0.9 Percent | GC-MS | Resolve DOI |
| Apiole | Unspecified | Essential oil | ≤ 5.1 Percent | GC-MS | Resolve DOI |
| Beta-thujone | Unspecified | Essential oil | ≤ 2.1 Percent | GC-MS | Resolve DOI |
| Camphor | Unspecified | Essential oil | ≤ 6 Percent | GC-MS | Resolve DOI |
| Camphor | Unspecified | Essential oil | ≥ 0.1 Percent | GC-MS | Resolve DOI |
| Carvone | Unspecified | Essential oil | ≤ 3.1 Percent | GC-MS | Resolve DOI |
| Fenchone | Unspecified | Essential oil | ≤ 23.7 Percent | GC-MS | Resolve DOI |
| Fenchone | Unspecified | Essential oil | ≥ 9.4 Percent | GC-MS | Resolve DOI |
| Methyleugenol | Unspecified | Essential oil | ≤ 3.4 Percent | GC-MS | Resolve DOI |
| Methylisoeugenol | Unspecified | Essential oil | ≤ 4.4 Percent | GC-MS | Resolve DOI |
| Myrcene | Unspecified | Essential oil | ≤ 1.6 Percent | GC-MS | Resolve DOI |
| Myrcene | Unspecified | Essential oil | ≥ 0.3 Percent | GC-MS | Resolve DOI |
| Saponins | Aerial part of plants | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Tannins | Unspecified | Essential oil | 12.9 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Hussein, MS., EI-Sherbeny, SE., Khalil, MY., Naguib, NY., Aly, SM. Growth characters and chemical constituents of Dracocephalum moldavica L. plants in relation to compost fertilizer and planting distance . Scientia horticulturae, 2006, vol. 108, no. 3, p. 322-331. DOI
- Aynehchi, Y., Sormaghi, M. H. Salehi., Amin, G. H., Soltani, A., Qumehr, N. Survey of Iranian plants for saponins, alkaloids, flavonoids and tannins. II. International Journal of Crude Drug Research, 1982, p. 61-70.
- Kakasy, A. Z., Lemberkovics, E., Kursinszki, L., Janicsak, G., Szoke, E. Data to the phytochemical evaluation of Moldavian dragonhead (Dracocephalum moldavica L., Lamiaceae). Herba polonica, 2002, p. 112-119.
- Kakasy, A. Z., Lemberkovics, E., Simandi, B., Lelik, L., Hethelyi, E., Antal, I., Szoke, E. Comparative study of traditional essential oil and supercritical fluid extracts of Moldavian dragonhead (Dracocephalum moldavica L.) . Flavour and fragrance journal, 2006, vol. 21, no. 4, p. 598-603. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.